Pleural tuberculosis
diseaseOn this page
Also known as pleura tuberculosistuberculosis of pleuratuberculous pleurisytuberculous pleuritis
Summary
Pleural tuberculosis (MONDO:0005922) is a disease and 3 clinical trials. Top therapeutic interventions include prednisolone. A subtype of extrapulmonary tuberculosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 3
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | pleural tuberculosis |
| Mondo ID | MONDO:0005922 |
| EFO | EFO:0007446 |
| MeSH | D014396 |
| DOID | DOID:106 |
| ICD-10-CM | A15.6 |
| NCIT | C26898 |
| SNOMED CT | 186172004 |
| UMLS | C0041326 |
| MedGen | 22517 |
| GARD | 0024256 |
| Anatomy (UBERON) | UBERON:0000977 |
| Is cancer (heuristic) | no |
Also known as: pleura tuberculosis · tuberculosis of pleura · tuberculous pleurisy · tuberculous pleuritis
Disease family
This is a subtype of extrapulmonary tuberculosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › primary bacterial infectious disease › tuberculosis › extrapulmonary tuberculosis › pleural tuberculosis
Related subtypes (12): abdominal tuberculosis, cardiac tuberculosis, central nervous system tuberculosis, gastrointestinal tuberculosis, laryngeal tuberculosis, lymph node tuberculosis, miliary tuberculosis, pericardial tuberculosis, skeletal tuberculosis, urogenital tuberculosis, ocular tuberculosis, cutaneous tuberculosis
Subtypes (2): tuberculous pneumothorax, tuberculous empyema
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 3.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 3 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00313066 | Not specified | UNKNOWN | Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion |
| NCT00338793 | Not specified | COMPLETED | Corticosteroids in the Treatment of Tuberculous Pleurisy |
| NCT00524147 | Not specified | COMPLETED | Drainage of Tuberculous Pleural Effusions |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| PREDNISOLONE | 4 | 1 |
Related Atlas pages
- Drugs: Prednisolone